✦ LIBER ✦

Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer

✍ Scribed by Milat, F.; Goh, S.; Gani, L.U.; Suriadi, C.; Gillespie, M.T.; Fuller, P.J.; Teede, H.J.; Strickland, A.H.; Allan, C.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel in Hormone-Refractory Metastat

✍ William R. Berry 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 48 KB

Docetaxel in Hormone-Refractory Metastat

✍ Ronald de Wit 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 50 KB

Docetaxel in Hormone-Refractory Metastat

✍ William K. Oh 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 48 KB

Lycopene: A novel drug therapy in hormon

✍ M.S. Ansari; N.P. Gupta 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Treatment in metastatic prostate cancer

✍ S. Vitello; F. Vacirca; E. Triglia; G. Giarratano 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 33 KB

PCK 3145 in metastatic hormone-refractor

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB